Adeghe v. Janssen Pharmaceuticals, Inc. et al
Jamal Adeghe |
Janssen Pharmaceuticals, Inc., Johnson & Johnson and Janssen Research and Development, LLC |
1:2016cv02235 |
March 25, 2016 |
US District Court for the Southern District of New York |
Foley Square Office |
New York |
Personal Inj. Prod. Liability |
28 U.S.C. ยง 1446 nr Notice of Removal |
None |
Available Case Documents
The following documents for this case are available for you to view or download:
Document Text |
---|
Filing 137 OPINION AND ORDER re: 127 MOTION for Summary Judgment filed by Janssen Pharmaceuticals, Inc. For the foregoing reasons, Defendant's motion for summary judgment is GRANTED as to all remaining claims. The pending mot ions in limine and motion to strike are DENIED as moot. The Clerk of Court is respectfully directed to close all open motions and to close the case. (Signed by Judge Lorna G. Schofield on 8/29/2018) (mro) Transmission to Orders and Judgments Clerk for processing. |
Filing 116 OPINION AND ORDER re: 79 MOTION for Reconsideration re; 74 Memorandum & Opinion,, . filed by Janssen Pharmaceuticals, Inc., 82 MOTION for Reconsideration . filed by Jamal Adeghe. For the foregoing reasons, th e parties' motions for reconsideration are DENIED. The upcoming trial and all pretrial dates are adjourned sine die. Defendant shall file a new motion for summary judgment by November 8, 2017, and Plaintiff shall file his opposition by November 22, 2017. The briefs shall not exceed 20 pages and shall not include a section reiterating the facts or procedural posture of the case. Defendant may file a reply not exceeding 8 pages by December 1, 2017. The Clerk of Court is respectfully directed to close the motions at Dkt. Nos. 79 and 82. Motions due by 11/8/2017. Responses due by 11/22/2017 Replies due by 12/1/2017. (Signed by Judge Lorna G. Schofield on 10/24/2017) (kgo) Modified on 10/24/2017 (kgo). |
Filing 74 OPINION AND ORDER re: 56 MOTION in Limine to Exclude Testimony of Dr. Barry Bercu. filed by Janssen Pharmaceuticals, Inc., 57 MOTION for Summary Judgment . filed by Janssen Pharmaceuticals, Inc.. For the foregoing r easons, Defendant's motion to preclude is DENIED and motion for summary judgment is GRANTED as to the express warranty claim and the failure-to-warn claims, but DENIED in all other respects. Defendant's request for oral argument is DENIED as moot. The Clerk of Court is respectfully directed to close the motion at Dkt. Nos. 56 and 57. (Signed by Judge Lorna G. Schofield on 8/30/2017) (kgo) |
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.